STOCK TITAN
  1. Home
  2. News
  3. NNOX

Nano X Imaging Ltd - NNOX STOCK NEWS

Welcome to our dedicated news page for Nano X Imaging (Ticker: NNOX), a resource for investors and traders seeking the latest updates and insights on Nano X Imaging.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Nano X Imaging's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Nano X Imaging's position in the market.

News
Nanox Announces Collaboration with AhealthZ and SCL Science to Enter South Korean Market
Rhea-AI Summary
Nanox partners with AhealthZ and SCL Science to advance Nanox.ARC 3D imaging system and AI solutions in South Korea, aiming to secure local authorizations and licenses. The collaboration includes integration of Nanox's AI solutions in remote image analysis and potential integration of Nanox.MARKETPLACE with SCL Science's teleradiology centers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.02%
Tags
none
-
News
Nanox Announces Fourth Quarter of 2023 Financial Results and Provides Business Update
Rhea-AI Summary
Nanox launches Nanox.ARC in the United States with installations across five states, marking a major advancement in medical imaging management. The company generated $2.4 million in revenue in Q4 2023, showing growth from the previous year. Nanox.ARC systems have begun scanning patients in the US and passed required tests in three states. Nanox.AI secured FDA clearance for HealthFLD, an AI-based software for fatty liver disease assessment. The ADOPT study demonstrated a sixfold increase in identifying patients with vertebral compression fracture. Nanox continues to advance in clinical trials and regulatory processes, aiming to provide transformative healthcare solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.73%
Tags
earnings
-
News
Nanox to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
Rhea-AI Summary
NANO-X IMAGING (NNOX) will report its financial results for Q4 and fiscal year 2023 on April 1, 2024. The CEO and CFO will host a conference call to discuss the results and business update.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.57%
Tags
conferences earnings
News
Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold
Rhea-AI Summary
NANO-X IMAGING LTD (NNOX) and Nanox.AI announce early findings from the ADOPT study, showing significant improvement in detecting vertebral compression fractures using AI technology in routine CT scans. The study identified up to six times more patients with spine fractures than the UK national average, leading to better patient outcomes and potential cost savings for healthcare systems.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.35%
Tags
AI
-
News
Nanox and Beilinson Hospital Announce Collaboration to Study Diagnostic Capabilities of Nanox.ARC for Detection of Lung and Chest Diseases
Rhea-AI Summary
NANO-X IMAGING LTD collaborates with Beilinson Hospital to conduct a clinical study evaluating the Nanox.ARC 3D imaging system for lung and chest disease detection. The study aims to assess the diagnostic capabilities of the system compared to conventional radiography, potentially reducing the need for advanced imaging and radiation exposure.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.66%
Tags
none
-
News
Nanox Receives FDA Clearance for HealthFLD, an Advanced AI-Based Software Empowering Clinicians in Assessment of Fatty Liver
Rhea-AI Summary
Nanox's HealthFLD AI software receives FDA clearance for automated liver attenuation analysis from CT scans, aiding in the early detection of metabolic diseases like MASLD. The software demonstrated high performance in detecting hepatic steatosis in a study, expanding Nanox's AI solutions for population health.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.09%
Tags
clinical trial AI
News
Nanox Mourns Death of Its Founder, Ran Poliakine
Rhea-AI Summary
Nanox Imaging Ltd announced the passing of its founder and non-executive chairman, Ran Poliakine, due to a medical condition. Mr. Poliakine was a serial entrepreneur with over 35 years of experience, who founded more than 20 companies and held over 70 patents in various fields. After founding Nanox and taking it public in 2020, he moved to a non-executive role in 2021. The company's CEO, Erez Meltzer, expressed deep condolences and emphasized the goal of bringing Nanox imaging solutions into widespread use to honor Ran's legacy and vision.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.32%
Tags
none
-
News
Nanox Announces Third Quarter of 2023 Financial Results and Provides Business Update
Rhea-AI Summary
NANO-X IMAGING LTD (NNOX) announced its third quarter results for 2023, revealing a net loss of $21.4 million and $2.5 million in revenue. The company achieved significant milestones such as entering into a manufacture and supply agreement with Varex Imaging Corporation and establishing its first U.S.-based commercial site and demonstration center. The company also received regulatory approvals and started the process of securing the CE mark designation in the European Union.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.54%
Tags
earnings
-
News
Nanox to Report Third Quarter 2023 Financial Results on November 28, 2023 and Reschedules Investor Day for December 4, 2023
Rhea-AI Summary
NANO-X IMAGING LTD (NASDAQ: NNOX) announced the release of its financial results for the quarter ended September 30, 2023 on November 28, 2023, and its upcoming Investor Day on December 4, 2023 in New York City. Interested parties can register for the conference call and access the live webcast through links provided on the Nanox website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.44%
Tags
conferences earnings
News
Nanox Continues Business as Planned, and Postpones Investor Day Scheduled for October 17, 2023
Rhea-AI Summary
NANO-X IMAGING postpones Investor Day due to recent events in Israel
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.96%
Tags
none
Stock NNOX logo
Nano X Imaging Ltd

Nasdaq:NNOX

NNOX Rankings

#2961 Ranked by Market Cap
#5018 Ranked by Stock Gains
N/A Ranked by Dividends

NNOX Stock Data

561.03M
55.12M
9.13%
22.76%
15.35%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Israel
Neve Ilan

About NNOX

nanox is developing the next generation of x-ray emitters based on groundbreaking nanotechnology. nanox emitters will finally bring x-ray imaging into the digital era, enabling novel 3d imaging systems with unmatched performance